Search

Complete abstract information will be provided to the CMSC Annual Meeting attendees on May 28, 2023.

CMSC Abstracts Search Form (Titles and Authors only)

Search Accepted Abstracts
Sending

Search Results

Year ID Type Category Title Authors
2022 QOL20 Poster Quality of Life and Outcomes

Avoidant Coping Predicts Quality of Life for Persons with Multiple Sclerosis with High Cognitive Reserve

Samantha M Vervoordt, M.S., Department of Psychology, The Pennsylvania State University, State College, PA and Peter A Arnett, Ph.D., Department of Psychology, Pennsylvania State University, State College, PA

2022 QOL21 Poster Quality of Life and Outcomes

Patient-Reported Outcomes for Patients Treated with Peginterferon Beta-1a: Plegridy Observational Program Interim Analysis

Sibyl Wray, MD1, Marco Salvetti, MD2, Gereon Nelles, MD3, Nydjie Grimes, MPH, BA4, Nicholas Belviso, PhD5 and Thijs Koster, MSc5, (1)Hope Neurology MS Center, Knoxville, TN, (2)Sapienza University, S. Andrea Hospital, Rome, Italy, (3)Neurology, NeuroMed Campus Hohenlind, Cologne, Germany, (4)Biogen, at the time of this analysis, Cambridge, MA, (5)Biogen, Cambridge, MA

2022 QOL22 Poster Quality of Life and Outcomes

Impact of Cognitive Impairment on Quality of Life and Work Productivity of Relapsing-Remitting Multiple Sclerosis Patients: A Systematic Literature Review

Lea Achrafie, MS1, Joelle Constantin, MS2, Maud Pacou, MS3, Jinender Kumar, MS4 and Tom Tencer, PhD4, (1)Amaris Consulting, Toronto, ON, Canada, (2)Amaris Consulting, Montreal, QC, Canada, (3)Amaris Consulting, Paris, France, (4)Bristol Myers Squibb, Princeton, NJ

2022 REH07 Poster Rehabilitation Posters

Rhythmic Transcranial Magnetic Stimulation (rTMS) As a Tool for Reducing Overall Levels of Fatigue in Patients with Multiple Sclerosis

Alice E Dias, Dr1, Demetrios C Agourakis, Medical Student2, Giovanna P Vidigal, Physiotherapist3, Andre V S Caetano, Physical educator3, Juliana AR Telles, MSc4, Bruna H Sciarinni, Physiotherapist4, Mauricio O Bando, Neuropsychologist5, Carlos B M Monteiro, Dr3 and Talita D Silva, Dr6, (1)Scientific Research, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil, (2)Medicine, Faculty of Medicine, University City of Sa?o Paulo (UNICID), São Paulo, Brazil, (3)University of São Paulo School of Arts, Sciences and Humanities (EACH), São Paulo, Brazil, (4)Physiotherapy, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil, (5)Neurorehabilitation, ABEM – Brazilian Multiple Sclerosis Association, Sao Paulo, Brazil, (6)Sao Paulo University, Sao Paulo, Brazil

2022 REH08 Poster Rehabilitation Posters

Translingual Neurostimulation By Portable Neuromodulation Stimulator System As a New Rehabilitation Therapy for Improving Gait in People with Multiple Sclerosis

Antonella Favit-VanPelt, MD, PhD1, Kim Skinner, PT, DPT1, Greg Maislin, PhD2, Nicole Strachan, BHK, MSc. P.Kin1 and Lola Abhulimen, MBA1, (1)Helius Medical Technologies, Newtown, PA, (2)Biomedical Statistical Consulting, Wynnewood, PA

2022 REH09 Poster Rehabilitation Posters

Pilot Study: Cognitive Rehabilitation Via Telehealth Yields Impressive Outcomes

Betty Mathew, SLP, Multiple Sclerosis Outpatient Rehabilitation, Shepherd Center, Atlanta, GA

2022 REH10 Poster Rehabilitation Posters

Do Device-Measured Physical Activity and Sedentary Behavior Differ By Depression Symptom Status in Persons with MS?

Catherine D Jones, MSPH1, Brenda Jeng, MS2, Petra Silac, B.S.2 and Rob Motl, PhD1, (1)Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, (2)Department of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL

2022 REH11 Poster Rehabilitation Posters

Strategies to Help Resistant People Improve Gait

Clare T Hartigan, PT, MPT, Multiple Sclerosis Outpatient Rehabilitation, Shepherd Center, Atlanta, GA

2022 REH12 Poster Rehabilitation Posters

Case Report: Blood Flow Restriction and Therapeutic Exercise for a Patient with Multiple Sclerosis and Advanced Disability

Evan T Cohen, PT, MA, PhD, NCS, Rehabilitation and Movement Sciences, Rutgers, The State University of New Jersey, Blackwood, NJ, Hannah Dwight, PT, DPT, PhD, Neurology, University of Colorado, Aurora, CO, Johnny Owens, BS, MPT, Owens Recovery Science, San Antonio, TX, Michael Bade, Michael Bade PT, DPT, PhD, OCS, FAAOMPT, University of Colorado, Denver, CO, Rashelle Hoffman, PT, DPT, PhD, Department of Physical Therapy, Creighton University, Omaha, NE and Mark M Manago, PT, PhD, Department of Neurology, University of Colorado School of Medicine, Aurora, CO

2022 REH13 Poster Rehabilitation Posters

Effects of in-Person, Telehealth, and Combined Wellness Programs on Functional Outcomes in Individuals with MS: A Retrospective Cohort Study Protocol

Emily Gard, SPT1, Jordan Lutz, SPT2 and Hina Garg, PT, MS, PhD, NCS1, (1)Rocky Mountain University of Health Professions, Provo, UT, (2)Salt Lake City, UT

2022 REH14 Poster Rehabilitation Posters

Transcranial Magnetic Stimulation Associated with Physical Therapy on Balance of People with Multiple Sclerosis: A PILOT Study

Juliana AR Telles, MSc1, Alice E Dias, Dr2, Bruna H Sciarini, physiotherapy3, Mauricio O Bando, Neuropsychologist4, Demetrios C Agourakis, Medical Student5, Giovanna Vidigal, physicaltherapist6, Carlos BM Monteiro, physicaltherapist6, Andre V S Caetano, Physical educator7 and Talita Dias, physicaltherapist6, (1)Physiotherapy, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil, (2)Scientific Research, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil, (3)physiotherapy, Brazilian Association of Multiple Sclerosis, São Paulo, Brazil, (4)Neurorehabilitation, ABEM – Brazilian Multiple Sclerosis Association, Sao Paulo, Brazil, (5)Medicine, Faculty of Medicine, University City of Sa?o Paulo (UNICID), São Paulo, Brazil, (6)Universidade de São Paulo, São Paulo, Brazil, (7)University of São Paulo School of Arts, Sciences and Humanities (EACH), São Paulo, Brazil

2022 REH15 Poster Rehabilitation Posters

Telerehabilitation on COVID 19 Pandemic Period Affecting Quality of Life and Fatigue of People with Multiple Sclerosis

Juliana AR Telles, physicaltherapist1, Alice E Dias, Dr2, Anna ELISA Moraes, physicaltherapist3, Francis Fávero, physicaltherapist4 and Acary Bulle, doctor3, (1)neurologia, Associação Brasileira de Esclerose Múltipla, São Paulo, Brazil, (2)Scientific Research, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil, (3)universidade federal de são paulo, são paulo, Brazil, (4)neurologia, universidade federal de são paulo, São Paulo, Brazil

2022 REH16 Poster Rehabilitation Posters

Combining Telerehabilitation with Functional Electrical Stimulation for Walking for People with Multiple Sclerosis: A Pilot Study

Lisa C Donahue, MPT, NCS1, Pierre Karashchuk, BA1,2, Elie Celnikier, ME1, Mohammed Aashyk Mohaiteen Hebsur Rahman, MS1, Juan M Rodriguez, BS1, Andrew Ekelem, PhD1 and Pierluigi Mantovani, BA1, (1)Evolution Devices, Berkeley, CA, (2)Neuroscience Program, University of Washington, Seattle, WA

2022 REH17 Poster Rehabilitation Posters

Occupational Therapy Interventions for Job Retention for Individuals with Multiple Sclerosis: A Case Study

Rebecca Cunningham, OTD, OTR/L, MSCS and Kayla Gan, MA, OTR/L, Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA

2022 REH18 Poster Rehabilitation Posters

Forced Exercise Training for Persons with Multiple Sclerosis

Ryan M Love, MS, Heritage College of Osteopathic Medicine, Ohio University, Cleveland, OH, Alexis Skolaris, BA, Cleveland Clinic, Cleveland, OH, Amanda Penko, PhD, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, Francois Bethoux, MD, Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH and Susan M Linder, DPT, Department of Physical Medicine and Rehabilitation, Cleveland Clinic, Cleveland, OH

2022 REH19 Poster Rehabilitation Posters

Professional Workforce Development for Rehabilitation in MS

Suzanne M Carron, OTR1, Marissa A Barrera, MS, MPhil, MSCS, CCC-SLP, PhD2, Valerie J Block, PT, DPTSc3, Salim Chahin, MD, MSCE4, Angelina Ciavarella, PT, DPT, NCS5, Rebecca Cunningham, OTD, OTR/L, MSCS6, Carleigh Dabritz, MS OTR/L, CPAM7, Meredith Drake, PT, DPT, NCS8, Elissa C Held Bradford, PT, PhD, NCS, MSCS9, Brian Hutchinson, PT, MSCS10, Rola A Mahmoud, MD11, Shaina Meyer, OTR/L, MSCS12, Katelyn Michtich, MBA13, Kelli Reiling Ott, OTD, OTR/L, MSCS14, Victoria Pavelko, CCC-SLP15, Kirsten Potter, PT, DPT, MS16, Emily Reilly, CPT17 and Alexius Sandoval, MD8, (1)Advocacy and Healthcare Access, National Multiple Sclerosis Society, Saint Louis, MO, (2)Speech Language and Hearing Sciences, Katz School for Science & Health, Yeshiva University, New York, NY, (3)Post-Doctoral Fellow within UCSF Physical Therapy, University of California San Francisco, San Francisco, CA, (4)Department of Neurology, Washington University in St. Louis, St. Louis, MO, (5)Physical Therapy, Oregon Health Sciences University, Portland, OR, (6)Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA, (7)Physical Medicine and Rehabilitation, John Hopkins, Baltimore, MD, (8)Physical Medicine and Rehabilitation, Johns Hopkins, Baltimore, MD, (9)Department of Physical Therapy and Athletic Training, Saint Louis University, St. Louis, MO, (10)Multiple Sclerosis Achievement Center, Dignity Health, Sacramento, CA, (11)Neurology, Saint Luke’s Marion Bloch Neuroscience Institute, Comprehensive MS center, Kansas City, MO, (12)Lou Ruvo Center for Brain Health, Cleveland Clinic, Las Vegas, NV, (13)Advocacy and Healthcare Access, National Multiple Sclerosis Society, Southern California & Nevada Chapter, Los Angeles, CA, (14)Occupational Therapy Education, The University of Kansas Medical Center, Kansas City, KS, (15)Virginian Rehab & Wellness Inc, Chantilly, VA, (16)Department of Physical Therapy Education, Rockhurst University, Kansas City, MO, (17)Advocacy and Healthcare Access, National Multiple Sclerosis Society, Washington, DC

2022 SYM01 Poster Symptom management

Variability of Spasticity in Multiple Sclerosis – Results from SEEN-MSS, a Large-Scale, Self-Reported Survey

Barry Hendin, MD1, Ben W Thrower, MD2, Scott D. Newsome, DO, MSCS, FAAN, FANA3, Robert Chinnapongse, MD4, Sherry Danese, BS, MBA5 and Jenifer Patterson, ARNP, MSCN4, (1)Center for Neurology and Spine, Phoenix, AZ, (2)Crawford Research Institute, Shepherd Center, Atlanta, GA, (3)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (4)Jazz Pharmaceuticals, Carlsbad, CA, (5)Outcomes Insights, Agoura Hills, CA

2022 SYM02 Poster Symptom management

Current Treatment for Spasticity in Multiple Sclerosis – Satisfaction, Limitations, and Future Directions

Barry Hendin, MD1, Ben W Thrower, MD2, Scott D. Newsome, DO, MSCS, FAAN, FANA3, Robert Chinnapongse, MD4, Sherry Danese, BS, MBA5 and Jenifer Patterson, ARNP, MSCN4, (1)Center for Neurology and Spine, Phoenix, AZ, (2)Crawford Research Institute, Shepherd Center, Atlanta, GA, (3)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (4)Jazz Pharmaceuticals, Carlsbad, CA, (5)Outcomes Insights, Agoura Hills, CA

2022 SYM03 Poster Symptom management

Fatigue in Active and Nonactive Primary and Secondary Progressive Multiple Sclerosis Patients in the United States

Crystal Watson, MS1, Natalia Sadetsky, MD, PhD1, Dhanalakshmi Thirumalai, PhD, MPH2, Arie Barlev, PharmD, MS1, Nikisha Grant, BSc, MSc3, Eddie Jones, BA3, Sasha Bogdanovich, MD, PhD2 and Kiren Kresa-Reahl, MD2, (1)Atara Biotherapeutics, South San Francisco, CA, (2)Atara Biotherapeutics, Thousand Oaks, CA, (3)Adelphi Real World, Bollington, Cheshire, United Kingdom

2022 SYM04 Poster Symptom management

Post Hoc Analysis of Nabiximols Efficacy By Concomitant Medication Use in 2 Enriched Placebo-Controlled Randomized Clinical Trials (RCTs)

Faria Amjad, MD1, Aaron L Boster, MD2, Javier Carod Artal, MD3, Robert Chinnapongse, MD4, Daniel Checketts, MSc5, Peyman Adjamian, MD5 and Joshua R. Steinerman, MD4, (1)Georgetown University, Washington, DC, (2)The Boster Center for Multiple Sclerosis, Columbus, OH, (3)Raigmore Hospital, NHS Highlands, Scotland, United Kingdom, (4)Greenwich Biosciences, Inc., Carlsbad, CA, (5)GW Research Ltd, Cambridge, United Kingdom

2022 SYM05 Poster Symptom management

Nabiximols Efficacy in MS Spasticity: Treatment Effects on Spasticity Numeric Rating Scale Score and Muscle Spasm Frequency in 2 Randomized Clinical Trials

Sajida Javaid, CCST, FRCP, FRCS, FCPS1, Fred D. Lublin, MD2, Jacqueline A Nicholas, MD, MPH3, Sylvia Klineova, MD2, Joris Berwaerts, MD4, Robert Chinnapongse, MD4, Daniel Checketts, MSc5 and Joshua R. Steinerman, MD4, (1)Bridgend Clinic, Wales, United Kingdom, (2)Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai, New York, NY, (3)OhioHealth Multiple Sclerosis Center, Columbus, OH, (4)Greenwich Biosciences, Inc., Carlsbad, CA, (5)GW Research Ltd, Cambridge, United Kingdom

2022 Poster

Perceptions of Newly Diagnosed Persons with Multiple Sclerosis on Exercise and Physical Activity – a Qualitative Study

David A Henning, PhD1, Lori Quinn, PT, EdD2, Andre Cabalang, BS3 and Nora E Fritz, PhD, PT, DPT, NCS1, (1)Neuroimaging and Neurorehabilitation Laboratory, Wayne State University, Detroit, MI, (2)Biobehavioral Sciences, Teachers College Columbia University, New York, NY, (3)Physical Therapy, Wayne State University, Detroit, MI

2022

Effectiveness of Different Dietary Approaches on Fatigue and Quality of Life in People with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis of Randomized Trials

Linda G. Snetselaar, PhD, RDN1, Joshua Cheek, BA2, Sara Shuger Fox, PhD2, Heather Healey, MA, MLS, AHIP3, Marin Schweizer, PhD4, Wei Bao, MD, PhD5, John A Kamholz, MD, PhD6 and Tyler J. Titcomb, PhD, RDN4, (1)Department of Epidemiology, University of Iowa, Iowa City, IA, (2)Central College, Pella, IA, (3)Hardin Library for the Health Sciences, University of Iowa, Iowa City, IA, (4)Department of Internal Medicine, University of Iowa, Iowa City, IA, (5)University of Science and Technology of China, Hefei, China, (6)Neurology, University of Iowa, Iowa City, IA

2022

Comorbidity between Multiple Sclerosis and Idiopathic Intracranial Hypertension: A Retrospective Cohort Study

Jay B Lusk, BSc1, Ailin Song, BA1, Paige E Sutton, MD2 and Suma Shah, MD2, (1)Duke University School of Medicine, Durham, NC, (2)Department of Neurology, Duke University, Durham, NC

2022

Multiple Sclerosis Patients Have Higher Full Employment Rates Than Other Patients Following in the Neuroimmunology Clinic.

Delaney Cairns, BS1, Mokshal H Porwal, BSc1, Amber Salter, PhD2, Samantha O’Dell, BA1, DeAnna Finnessy, MA1, Camila Ishueva, BS1, Murali Palathinkara, BS1, Abrahim N Razzak, BS1 and Ahmed Z Obeidat, MD, Ph.D.1, (1)Neurology, Medical College of Wisconsin, Milwaukee, WI, (2)Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX

2021 Late-Breaking Psychosocial factors

Connect Trial of Online Professional Support Groups for Black and Latinx People Living with MS

V. M. Leavitt, A. Cohen, J. E. Duncan, and S. Magosin

2021 Late-Breaking Disease-modifying therapy

Dimethyl Fumarate Is Associated with Lower Rates of Infection and Lower Infection-Related Healthcare Costs When Compared with Ocrelizumab

J. Nicholas, M. Gudesblatt, M. Garabedian, N. Belviso, C. Shen, C. Geremakis, S. L. Shankar, J. P. Mendoza, and J. B. Lewin

2021 Late-Breaking Self-care

Patient-Centered Education and Care Coordination Initiative to Improve Self-Management Skills in Latinos with Multiple Sclerosis

A. L. Castro

2021 Late-Breaking Disease-modifying therapy

US Real World Experience Switching from Infusion and S1P Therapies to Cladribine Tablets: A Single Center Study

R. Dukkipati

2021 Late-Breaking Disease-modifying therapy

Early Experience with Cladribine Tablets in an Aging Patient Population

D. Sellers and D. Negroski

2021 Late-Breaking Disease-modifying therapy

Humoral and T-Cell Responses to Sars-Cov-2 Vaccination in Multiple Sclerosis Patients Treated with Ocrelizumab

J. D. Katz, A. J. Bouley, E. S. Lathi, E. A. Douglas, R. M. M. Jungquist, and I. L. O’Shea

2021 Late-Breaking Case Reports/Case Series

Multiple Sclerosis Diagnosis: Challenges in Telehealth

L. Shiver

2021 Late-Breaking Quality of life and outcomes

Patient Practices and Experiences during COVID-19 Among Individuals across the United States Enrolled in MS Lifelines Patient Support Program

J. Nicholas, D. S. Mackie, H. Costantino, L. Lebson, E. Mulvihill, and A. L. Philips

2021 Late-Breaking Disease-modifying therapy

Sustained B-Cell Depletion By Inebilizumab Is Associated with Decreased Disease Activity in Aquaporin-4 Seropositive Neuromyelitis Optica Spectrum Disorder

J. L. Bennett, O. Aktas, W. A. Rees, M. A. Smith, D. She, S. J. Pittock, B. G. Weinshenker, F. Paul, D. M. Wingerchuk, H. J. Kim, E. Katz, M. Levy, and B. A. Cree

2021 Late-Breaking Disease-modifying therapy

The Humoral Response to Sars-COV-2 Vaccines in MS Patients: Impact of Dmt, Lymphocyte Count, Immunoglobulins, and Vaccine Type

H. Abboud, C. Jakubecz, S. Woodson, and A. Serra

2021 Late-Breaking Disease-modifying therapy

Interim Results of Open-Label Multicenter Phase 4 Study Assessing Immune Response to Influenza Vaccine in Patients with Relapsing Multiple Sclerosis Treated with Ofatumumab

J. Gitt, E. B. Lucassen, J. Stankiewicz, X. Meng, and B. Weinstock-Guttman

2021 Late-Breaking Disease-modifying therapy

Pregnancy Outcomes in Patients with Multiple Sclerosis Following Exposure to Ofatumumab

K. Hellwig, B. Yamout, R. Bove, P. Katkuri, U. S. Topphoff, D. Stoneman, R. Zielman, R. Pingili, and M. Houtchens

2021 Late-Breaking Epidemiology and genetics

Geographic Variance of MS Prevalence in the United States

M. Hittle, G. Cutter, M. T. Wallin, W. J. Culpepper II, A. M. Langer-Gould, R. A. Marrie, W. Kaye, L. Wagner, N. LaRocca, and L. Nelson

2021 Late-Breaking Neuroimmunology and disease models

Temporal Trends in Humoral and Cellular Immune Responses to Sars-Cov-2 mRNA Vaccines Among Multiple Sclerosis Patients Treated with Natalizumab, Ocrelizumab or Fumarates

P. Repovic, J. Choi, S. Hong, J. Reola, J. Bowen, P. Qian, J. Heath, and J. Goldman

2021 Late-Breaking Methods of Care

Evaluating the Impact of Administering Ocrelizumab Via a Home Infusion on Safety and Patient Reported Outcomes

K. V. Nair